Use of the dierential display technique to isolate progestin-regulated genes in T-47D human breast cancer cells led to identi®cation of a novel gene, EDD. The cDNA sequence contains a 2799 amino acid open reading frame sharing 40% identity with the predicted 2894 amino acid product of the Drosophila melanogaster tumor suppressor gene hyperplastic discs, while the carboxy-terminal 889 amino acids show 96% identity to a rat 100 kDa HECT domain protein. EDD mRNA was progestin-induced in T-47D cells and was highly abundant in testes and expressed at moderately high levels in other tissues, suggesting a broad role for EDD. Anti-EDD antibodies immunoprecipitated an approximately 300 kDa protein from T-47D cell lysates. HECT family proteins function as E3 ubiquitin-protein ligases, targeting speci®c proteins for ubiquitin-mediated proteolysis. EDD is likely to function as an E3 as in vitro translated protein bound ubiquitin reversibly through a conserved HECT domain cysteine residue. EDD was localized by FISH to chromosome 8q22, a locus disrupted in a variety of cancers. Given the homology between EDD and the hyperplastic discs protein, which is required for control of imaginal disc growth in Drosophila, EDD potentially has a role in regulation of cell proliferation or dierentiation.
Introduction
The control of cell proliferation and dierentiation in the normal breast and in breast cancer involves complex actions and interactions of steroid hormones (in particular estrogen and progesterone), peptide hormones and growth factors Dickson and Lippman, 1995) . How these agents act at critical control points within the cell cycle to in¯uence progression through the cycle or exit to enter a pathway of dierentiation is only partially understood (Musgrove et al., 1991; Prall et al., 1997; Musgrove et al., 1998) . Progestins are responsible for mammary gland lobuloalveolar development during pregnancy (Lydon et al., 1995) , although there is evidence for a more predominant role for estrogens than progestins in stimulating epithelial cell proliferation in the normal premenopausal breast (Laidlaw et al., 1995; Sutherland et al., 1998) Progestins both stimulate and inhibit breast cancer epithelial cell proliferation in vitro but the predominant eect is growth inhibition probably via induction of differentiation (Musgrove et al., 1991; Groshong et al., 1997; Musgrove et al., 1998; Sutherland et al., 1998) Progestin action is mediated primarily through the progesterone receptor (PR), which acts as a transcriptional transactivator for a largely unde®ned set of progestin-responsive genes which may in turn transcriptionally or post-transcriptionally in¯uence additional genes or gene products. Only a limited number of genes have been implicated in progestin action on cell proliferation. Studies from this laboratory have identi®ed c-myc and cyclin D1 as major downstream targets of progestin-stimulated cell cycle progression in human breast cancer cells (Musgrove et al., 1991; while the delayed growth inhibitory eects of progestins involve decreases in cyclin D1 and E gene expression (Groshong et al., 1997; Musgrove et al., 1998) . While progestin eects on c-myc gene expression are rapid and occur within minutes, eects on cyclin expression begin several hours later, pointing to the presence of unde®ned earlier events.
Since progestin action is complex and is likely to involve multiple genes, many of which are currently unknown, the dierential display RT ± PCR technique (DD ± PCR) (Liang and Pardee, 1992 ) was adopted to identify target genes in cultured human breast cancer cells. We have previously demonstrated the utility of this approach by the cloning of PRG1, a gene having signi®cant homology with isoforms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (Hamilton et al., 1997) . Using the same technique a novel progestin-regulated gene, EDD, has been identi®ed. Based on the sequence similarity reported here, EDD appears to be a human homolog of the Drosophila tumor suppressor gene hyperplastic discs (hyd) (Mans®eld et al., 1994) . Although the function of the HYD protein is unknown, signi®cant homology exists between its carboxyl terminus and those of human E6-AP and a number of proteins identi®ed through database searches . These HECT domain (homology to E6-AP carboxyl terminus) family proteins function as ubiquitin-protein ligases (E3 enzymes) Hatakeyama et al., 1997) , playing a role in the ubiquitination cascade that targets speci®c substrate proteins for proteolysis. Only a few mammalian E3 genes have been cloned to date, namely E6-AP Schener et al., 1993) , UreB1 (Gu et al., 1994) , Nedd4 (Kumar et al., 1997a) and Itch (Perry et al., 1998) .
In the present study the cDNA cloning and initial characterization of a new human E3, EDD (E3 identi®ed by Dierential Display), is reported. The EDD protein has a carboxy-terminal HECT domain containing a cysteine residue that covalently binds ubiquitin. As this amino acid is conserved in all known HECT domain-containing E3 enzymes, and is involved in the transfer of ubiquitin, it is proposed that EDD is a novel human ubiquitin-protein ligase.
Results

Isolation and Northern blot analysis of a progestin regulated cDNA
The dierential display technique was used to identify mRNAs in T-47D human breast cancer cells with altered levels of expression in response to treatment with the synthetic progestin ORG 2058 for 3 h. When the anchored primer, 5'ACGACTCACTATAG-GGCT 12 AC was used in conjunction with the arbitrary primer, 5'ACAATTTCACACAGGAGCTAGCAGAC, a cDNA fragment of approximately 850 bp that was more abundant in treated samples than in control samples was identi®ed and designated EDD ( Figure  1a ). Northern analysis of total cellular RNA from T-47D cells showed that transcription was required for the observed ORG 2058 induction of EDD mRNA levels as this was blocked in the presence of actinomycin D (Figure 1b) . Induction was also prevented by cycloheximide, suggesting that EDD is not directly transcriptionally regulated by progestin acting via the PR (Figure 1c) .
The tissue speci®city of EDD gene expression was investigated by hybridizing Northern blots of polyA + RNA isolated from human tissues with the EDD cDNA fragment. A single transcript of 9.5 kb was detected in a variety of tissues (Figure 2a ) with the highest expression in testis, heart, placenta and skeletal muscle. Hybridization to a more quantitatively loaded RNA dot blot (Figure 2b ) con®rmed that EDD is expressed at varying levels in all tissues examined and that the mRNA was most abundant in testis and expressed at high levels in brain, pituitary and kidney. Identi®cation of EDD by dierential display. Total RNA obtained from T-47D cells treated with ORG 2058 or vehicle control (ethanol) for 3 h was used as a template for dierential display PCR reactions. The PCR products were separated on a 4.5% polyacrylamide denaturing gel and visualized by autoradiography. The arrow indicates the EDD DD-PCR product (DD5-1; see Figure 3a ) which is present at a higher level in the progestin treated (ORG 2058) compared with control lane. (b) Con®rmation of the progestin induction of EDD by Northern blot analysis. T-47D cells proliferating in medium supplemented with 5% charcoaltreated FCS were treated with 10 nM ORG 2058 or ethanol vehicle (CONTROL) in the presence or absence of actinomycin D (ACT) and after 3 h total RNA was harvested for Northern analysis. The Northern blot was probed with the EDD clone P19. (c) Eect of cycloheximide on progestin induction of EDD mRNA. T-47D cells proliferating in medium supplemented with 5% charcoal-treated FCS were treated with ORG 2058 (10 nM), cycloheximide (CHX, 20 mg/ml), ORG 2058 and CHX simultaneously or ethanol vehicle and harvested for total RNA at 1 h. The Northern blot was probed with the EDD DD-PCR fragment DD5-1 Signi®cant levels of expression were also observed in placenta, uterus, prostate, stomach, fetal lung and various brain tissues. EDD mRNA was also expressed in a range of breast cancer cell lines, not all of which are progestin-responsive (not shown).
Cloning of the full length EDD cDNA
The original DD5-1 fragment isolated by DD PCR was 850 bp in length and is shown schematically in Figure  3a . The DNA sequence of this fragment had no homology to sequences of any known human genes. To obtain the complete coding sequence from which EDD was derived a combination of 5'RACE and screening of human heart and placenta cDNA libraries was used. This resulted in a series of overlapping clones covering 8.5 kb of sequence (Figure 3a ; Genbank Accession AF006010). Analysis of the sequence revealed an open reading frame of 2799 amino acids (Figure 3b ). The EDD sequence was divided into overlapping 1800 bp segments and used in Blastx searches of the GenBank database. The only homology to a human sequence of known function was to polyA binding protein across 50 amino acids (50%, Figure 3b ) although the similarities among mammalian polyA binding proteins in this stretch are usually in the vicinity of 100%.
The DNA sequence of EDD showed signi®cant similarity to two sequences in the database. Both of + RNA from human tissues. The blot was hybridized with the P19 cDNA clone of EDD. Row A: 1, whole brain; 2, amygdala; 3, caudate nucleus; 4, cerebellum; 5, cerebral cortex; 6, frontal lobe; 7, hippocampus; 8, medulla oblongata; Row B: 1, occipital lobe; 2, putamen; 3, substantia nigra; 4, temporal lobe; 5, thalamus; 6, sub-thalamic nucleus; 7, spinal cord; Row C: 1, heart; 2, aorta; 3, skeletal muscle; 4, colon, 5, bladder; 6, uterus; 7, prostate; 8, stomach; Row D: 1, testis; 2, ovary; 3, pancreas; 4, pituitary gland; 5, adrenal gland; 6, thyroid gland; 7 , salivary gland; 8, mammary gland; Row E: 1, kidney; 2, liver; 3, small intestine; 4, spleen; 5, thymus; 6, peripheral leukocyte; 7, lymph node; 8, bone marrow; Row F: 1, appendix; 2, lung; 3, trachea; 4, placenta; Row G: 1, fetal brain; 2, fetal heart; 3, fetal kidney; 4, fetal liver; 5, fetal spleen; 6, fetal thymus; 7, fetal lung a b Figure 3 Cloning and predicted amino acid sequence of EDD. (a) A schematic representation of EDD structure with a restriction map for the EDD cDNA indicating the sites used for cloning the full-length EDD construct and the cDNA clones used to derive the EDD sequence shown beneath. The DD-PCR cDNA fragment identi®ed by dierential display was designated DD5-1 and a cDNA clone derived from the 5' RACE product and the original DD-PCR product, DD5-2. All cDNA clones were isolated from a human placenta cDNA library with the exception of H1 which was isolated from a human heart cDNA library. (b) Predicted amino acid sequence of EDD. There are two regions with high homology (*60%) to HYD (a central sequence and a carboxyl sequence containing the HECT domain) and these and other highly conserved sequences are shown in bold type, while two putative nucelar localization signals are boxed. The HECT domain is underlined and in bold type and includes a conserved cysteine at residue 2768 (boxed). A region showing homology to polyA-binding proteins is italicized (aa 2395 ± 2445) and the peptide sequence to which antiserum AbPEP1 was raised is underlined (aa 2469 ± 2484). The numbers refer to positions of amino acids these genes encode proteins belonging to the HECT family of ubiquitin-protein ligases, although their speci®cities are unknown. HECT proteins contain a conserved domain of approximately 300 amino acids that contains a cysteine residue able to bind ubiquitin via a thioester linkage. Nucleotides 5667 to 8502 of EDD were 88% identical to the rat 100 kDa protein cDNA sequence (Muller et al., 1992) , nucleotides 572 ± 740 and 3498 ± 3867 were 69% identical to two regions of the Drosophila melanogaster hyperplastic discs gene (hyd) and nucleotides 7560 ± 8430 were 60% identical to a third region of hyd (Mans®eld et al., 1994) . The putative initiation codon is surrounded by a consensus sequence for strong translational initiation (ACCAT-GA (Kozak, 1987) ) and corresponds to a possible start codon of the Drosophila hyd gene (Mans®eld et al., 1994) . The stop codon corresponds to that shared by the rat 100 kDa protein and hyd genes. Like EDD, both the hyd and rat 100 kDa protein genes have estimated mRNA transcript sizes of 9.5 kb (Muller et al., 1992; Huibregtse et al., 1995) . The predicted EDD protein is identical to HYD at 40% of amino acid residues and similar at 64% of residues, while the carboxyl third of EDD is 96% identical and 98.5% similar to rat 100 kDa protein. The most highly conserved regions between HYD and EDD are designated by bold type in Figure 3b . The longest conserved regions between EDD and HYD are a central domain of approximately 400 amino acids (58% identity, 72% similarity) and the carboxyl 300 amino acids which include the HECT domain and conserved cysteine residue (64% identity, 80% similarity). These regions also show considerable similarity to a possible C. elegans homolog of HYD contained within two overlapping cosmids (Genbank Accession No. G2652994 and G2653017) and the alignments of these sequences are shown in Figure 4a and b. The HECT domain showed around 30% identity and 50% similarity with other HECT proteins including yeast RSP5 or PUB-1 and RAD26 (van Gool et al., 1994; Huibregtse et al., 1995; Nefsky and Beach, 1996) , and the mammalian proteins UreB1 (Gu et al., 1994) , Nedd-4 (Nagase et al., 1995; Staub et al., 1996; Hatakeyama et al., 1997; Kumar et al., 1997a) and E6-AP Schener et al., 1993; Hatakeyama et al., 1997) . Apart from two putative nuclear localization signals (Dingwall and Laskey, 1991) , no other consensus functional domains were identi®ed within the EDD sequence.
Chromosomal localization of the EDD gene
FISH was used to localize the gene for EDD. Eighteen metaphases from a normal male were examined for uorescent signal. Seventeen of these metaphases showed signal on one or both chromatids of chromosome eight in the region q22. High resolution studies of eight metaphases showed signal at q22.3 ( Figure 5 ). There was a total of four non-speci®c background dots observed in these 18 metaphases. A similar result was obtained from hybridization of the probe to 11 metaphases from a second normal male (data not shown). This localization was consistent with independent assignment of an EST corresponding to EDD (EST116344) using the radiation hybrid panel Genebridge 4.
Characterization of EDD protein
A rabbit antiserum (AbPEP1) was raised against an EDD-speci®c peptide matching a sequence towards the carboxyl terminus of the protein (underlined in Figure  3b ). Strong cross-reactivity with EDD was demonstrated by Western blotting of a truncated (100 kDa) recombinant protein expressed in Sf9 cells using a baculovirus system (Figure 6a) . A second strongly immunoreactive band of approximately 200 kDa was also seen, but this appeared to be non-speci®c as antibody binding was not competed by the EDD peptide. The full length EDD cDNA was cloned into pBluescript and translated in vitro in a rabbit reticulocyte lysate system. The size of the major product was in agreement with the expected molecular mass of the protein as predicted from the amino acid sequence (*300 kDa, Figure 6b ). The identity of the translated protein was con®rmed by immunoprecipitation from either translation reactions or T-47D whole cell lysates with AbPEP1 ( Figure 6b ). Western blotting of whole cell lysates from T-47D cells using AbPEP1 detected two major bands, both abolished in the presence of competing peptide ± a major species at approximately 230 kDa and a minor species of higher molecular mass (Figure 6c ). This latter band corresponds in size to that of the in vitro translated protein and is immunoprecipitated by AbPEP1 (Figure 6c ) and by two other EDD-speci®c peptide antibodies (not shown). However, the 230 kDa protein is not immunoprecipitated from cell lysates by these antibodies. As a single EDD mRNA transcript was detected on Northern blots, we at ®rst hypothesized that the EDD protein may be processed to the 230 kDa form which is folded in a way that is not susceptible to immunoprecipitation in its native state. However, transient expression of full length EDD in HEK-293 cells resulted in a large increase in the 300 kDa species relative to endogenous levels, whereas levels of the 230 kDa protein remained unchanged (Figure 6d ), strongly suggesting that the 230 kDa protein is not an EDD gene product. Western blotting of whole cell lysates from a number of normal breast and breast cancer epithelial cell lines showed that EDD protein was expressed in all immortalized and cancer cell lines but not in a normal breast cell line, 184 ( Figure 7) .
Identity of the rat gene product
The previously described rat cDNA that is highly homologous to the EDD gene reportedly gives rise to a 100 kDa protein, inferred from cDNA sequence data which showed several in-frame stop codons upstream of the putative initiation codon (Muller et al., 1992) , corresponding to amino acid residue 1910 of EDD. These stop codons were not present in the EDD cDNA. Furthermore, although we were able to con®rm that an anti-HYD antibody detected an approximately 100 kDa protein in rat muscle lysates, this species was not detected by AbPEP1 even though the predicted sequences of human and rat proteins are identical at every residue of the peptide used to raise the AbPEP1 antibody. This led us to question whether the 100 kDa protein was the actual rat gene product. We cloned a segment of rat cDNA containing the stretch of sequence upstream of the proposed initiation codon and found an additional base that, by changing the reading frame, removes the upstream stop codons (Figure 8 ). Correction of this apparent error results in a rat cDNA sequence that closely matches the human cDNA, in which a continuous open reading frame exists throughout the sequence. While the rat cDNA sequence corresponding to the amino terminal two-thirds of EDD has not been cloned, a number of mouse expressed sequences covering parts of this region are recorded in the GenBank database (Accession No. AA183561, AA177260, AA183970, AA231351, AA087561) and these show comparable levels of similarity with the EDD DNA sequence to that seen with the published rat sequence. Thus it appears that the true product of the rat gene is not a 100 kDa protein but may exist as a larger species. In rat lysates, however, AbPEP1 does not detect a protein having a molecular weight consistent with the human (EDD) and Drosophila (HYD) gene products.
Ubiquitin binding by EDD
A critical feature of the HECT family of E3 enzymes is their ability to reversibly form thioesters with ubiquitin at a conserved cysteine residue within the HECT domain. This property has been demonstrated for the HECT proteins human E6-AP, rat 100 kDa protein and yeast RSP5 where the thioester linkage remains intact in the absence of reducing agents but is broken in the presence of 100 mM DTT . Substitution of the conserved cysteine residue prevents ubiquitin thioester bond formation. However, this property has not been shown for the HYD protein.
To assess the potential of EDD to function as an E3
we tested whether EDD could form a reversible bond with ubiquitin via the conserved cysteine, C2768.
35
Slabeled in vitro translated truncated protein (*100 kDa of carboxyl terminus sequence) was incubated with puri®ed GST-ubiquitin fusion protein in the presence or absence of DTT before SDS ± PAGE (Figure 9a ).
In the absence of DTT an additional higher molecular mass protein band was observed that corresponded to the expected size of an EDD-GSTubiquitin conjugate (*130 kDa, upper arrow in Figure  9a ). This species was abolished in the presence of 100 mM DTT suggesting involvement of a thioester bond in its formation. This was con®rmed by experiments with an in vitro translated protein containing a C2768A mutation: binding of GSTubiquitin was not seen under these conditions ( Figure  9a) . A species of slightly higher molecular mass than EDD was also observed (lower arrow in Figure 9a) , consistent with the formation of ubiquitin-EDD conjugates, ubiquitin being present as a component of the rabbit reticulocyte lysate. Again this was not observed using the mutant protein or in the presence of 100 mM DTT. Similar results were achieved with full length EDD protein obtained (though at lower yield) by in vitro translation (Figure 9b ).
Discussion
Application of the dierential display PCR technique to a cultured human breast cancer cell model in which clearly de®ned proliferative responses to progestins are observed has led to the identi®cation of a novel gene, EDD, a likely human homolog of the Drosophila melanogaster tumor suppressor gene hyperplastic discs (Mans®eld et al., 1994) . EDD is also highly homologous to the partial published sequence for the cDNA encoding the rat 100 kDa protein (Muller et al., 1992) . All three genes produce large (approx 9.5 kb) mRNAs and the predicted entire EDD open reading frame of 2799 amino acids shares 40% identity with that of Drosophila hyd while the carboxy-terminal 889 amino acids of EDD share 96% identity with the rat protein.
Western analysis showed that the EDD gene product is a protein of approximately 300 kDa. This protein is also immunoprecipitated by three dierent peptidespeci®c EDD antibodies and also corresponds to the size of the major in vitro translated gene product. The large discrepancy in the predicted size of the human and rat proteins was apparently resolved by reexamination of the rat cDNA sequence which disclosed an error in the published translation start site, pointing to the likelihood that a larger gene product exists.
At their carboxyl termini EDD, its rat homolog and HYD all contain a highly homologous HECT domain, indicating membership of a larger family of proteins which function as ubiquitin protein ligases (E3s). The Amino acid residues conserved in at least two of the three proteins are indicated by bold type. Numbers refer to positions of amino acids in the EDD sequence. (b) Similarity between HECT domains of EDD, HYD and a possible C. elegans homolog. The carboxy-terminal 325 amino acids of EDD, including the HECT domain, are aligned with equivalent sequence from the HYD and C. elegans proteins. Amino acid residues conserved in at least two of the three proteins are indicated by bold type. Numbers refer to positions of amino acids in the EDD sequence Figure 5 Chromosomal localization of the EDD gene. Metaphase showing FISH with the H1 probe. Normal male chromosomes were stained with DAPI. Hybridization sites on chromosome 8 are indicated by an arrow ubiquitination of target proteins occurs by the action of multiple interacting proteins: a ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzymes (E2) and ubiquitin-protein ligases (E3). Substrate speci®city is largely determined by E3s, which bind and transfer ubiquitin to the target protein following interaction with speci®c E2s. The key feature of the HECT class of E3s is their ability to covalently bind ubiquitin through a conserved cysteine residue located in their HECT domains . This property was demonstrated for EDD using in vitro translated protein that lost the ability to bind ubiquitin if the conserved cysteine (C2768) was substituted and we therefore conclude that EDD is an E3.
Few E3 genes have been cloned (only two from human) but others are likely to exist as ubiquitindependent proteolysis is involved in many cellular processes and targets many known proteins. Ubiquitinmediated proteolysis is critical in the control of cell cycle progression, being responsible for the periodic destruction of key cell cycle regulators including cyclins (King et al., 1996; Won and Reed, 1996; Diehl et al., 1997) and cyclin-dependent kinase inhibitors (Pagano et al., 1995; Benito et al., 1998) and also targeting transcription factors (Palombella et al., 1994; Orian et al., 1995; Musti et al., 1996; , the tumor suppressor protein p53 and cell-cell signaling components such as b-catenin (Orford et al., 1997) . Disruption of the murine Itch locus, which encodes an E3, caused hyperplasia in lymphoid and gastrointestinal epithelial tissues and an abnormal in¯ammatory response (Perry et al., 1998) while mutations in E6-AP in humans results in neurological abnormalities, indicating critical, and perhaps tissue speci®c, roles for E3 proteins (Kishino et al., 1997) .
Although substrates for EDD and its rat and Drosophila homologs have yet to be de®ned, conservation between the central domain of EDD and that of HYD suggests that this region has an important function, perhaps in substrate recognition. For the yeast E3 Rsp5, substrate speci®city is determined by the amino terminal domain and does not require the HECT domain (Huibregtse et al., 1997) . Alternatively, this region could be involved in the binding of as yet unknown E2 proteins that interact speci®cally with EDD. The mouse E3 Nedd4 has at least two distinct E2 binding domains, only one of which is within the HECT domain (Hatakeyama et al., 1997) while human E6-AP requires only the HECT domain for E2 recognition (Kumar et al., 1997b) . As the protein produced from the truncated EDD construct still binds Total cell lysates from a range of cell lines were separated by SDS ± PAGE through a 6% gel, transferred to nitrocellulose and blotted with AbPEP1. 184 is a normal breast cell line, 184B5 an immortalized derivative, and the remainder are breast cancer cell lines, MCF-7M being a sub-line of MCF-7 Figure 8 Sequence of the rat 100 kDa protein cDNA. Autoradiograph of the sequencing gel obtained when one clone was sequenced using the EDD-speci®c FC2 primer, with the sequence (a) listed alongside the autoradiograph. The published sequence (b (Muller et al., 1992) ) is shown alongside and the missing base denoted by an asterisk a b Figure 9 Ubiquitin thiol ester formation by EDD. In vitro translation of truncated (a) or full-length (b) EDD wild type or mutant (C2768A) protein in the presence of [ 35 S]methionine was followed by a 10 min incubation at 258C either with or without puri®ed GST-ubiquitin fusion protein (or GST in part a). Samples were resolved by SDS ± PAGE (A, 7% gel; B, 6% gel) following either incubation at 258C for 20 min in non-reducing sample buer containing 4 M urea or boiling in sample buer containing 100 mM DTT. Ubiquitin-and GST-ubiquitin-bound forms are marked with arrows ubiquitin reversibly, at least some E2 recognition function is present in this carboxyl domain. Other possible functions of the conserved central domain include cellular localization or translocation between cytoplasm and nucleus, cofactor association or phosphorylation.
Although ubiquitination is clearly involved in steroid-responsive processes such as regulation of cell cycle progression, speci®c regulation of ubiquitin pathways by steroid hormones has not previously been reported. The precise role of EDD in progestin action is unknown, particularly whether it participates in those key early events that occur in response to this hormone and which are ultimately responsible for its eects on cell proliferation and dierentiation. Progestin regulation of EDD mRNA, which requires de novo protein synthesis, is transient with maximal levels three-to fourfold above control observed at 6 h. This increase in EDD expression levels therefore precedes the increase in the S phase fraction of T-47D cells following ORG 2058 treatment under the same conditions, which typically occurs at 12 to 14 h (Musgrove et al., 1991) and hence is consistent with a possible role in control of cell cycle progression. Similar levels of EDD induction were observed in antiestrogenarrested MCF-7 breast cancer cells treated with 17b-estradiol (not shown), suggesting this may be a generalized response to mitogens.
However, given that EDD is also expressed in non progestin target tissues, a more widespread role than speci®cally mediating progestin eects is expected. Information on the biological role of HYD from mutagenesis studies in Drosophila (Mans®eld et al., 1994) may ultimately give clues as to the function of EDD. The null hyd phenotype is lethal in the pupal or larval stages, as are severe mutations. Less severe mutations result in overgrowth (hyperplasia) of larval imaginal discs (the larval centers of cell proliferation that give rise to adult structures such as wings, legs and antennae), apparently caused by a failure to terminate cell proliferation when the discs reach their characteristic size, hence the de®nition of hyd as a tumor suppressor gene. Surviving adults are sterile due to germ cell defects, and interestingly, high expression levels of EDD and rat 100 kDa protein mRNA are seen in human and rat testes, suggesting a critical function in this organ.
Studies of a number of human homologs of Drosophila tumor suppressor genes strongly suggest that these genes have similar roles in both species in controlling cell proliferation, and that such genes can be important in human heritable and sporadic cancers, for example patched (Johnson et al., 1996) , mutations of which are linked to basal cell carcinoma, and discs large (Kishino et al., 1997; Matsuura et al., 1997) , a target of the APC gene which is mutated in sporadic colorectal tumors and familial adenomatous polyposis coli. The possible involvement of EDD in human tumorigenesis and tumor progression is therefore of particular interest. The EDD gene locus at chromosome 8q22 is often disrupted in a variety of cancers, being deleted in adenocarcinoma of the ovary and lung (Sato et al., 1994; Mitelman et al., 1997) , hepatocellular carcinoma (Piao et al., 1998) and head and neck squamous cell carcinoma (Nawroz et al., 1994) , ampli®ed in many tumor types including gastrointestinal and primary breast cancers (Muleris et al., 1994; El-Rifai et al., 1996) and involved in translocations in acute myeloid leukemia (Erickson et al., 1992) . Chromosome 8q22 is also a region aected in the human developmental disorder Klippel-Feil syndrome .
In summary, EDD, a novel human gene, has been identi®ed and appears to be a homolog of the Drosophila tumor suppressor gene hyperplastic discs. Its properties suggest the EDD protein is a member of the HECT domain family of ubiquitin-protein ligases. Major priorities for ongoing research are the identi®cation of speci®c protein substrates for this enzyme and to determine whether the EDD gene has a tumor suppressor function that might be disrupted in human cancers.
Materials and methods
Reagents
Steroids and growth factors were obtained from the following sources: ORG 2058 (16a-ethyl-21-hydroxy-19-norpregn-4-en-3,20-dione), Amersham Australia Pty Ltd (Sydney, Australia); human transferrin (Sigma Chemical Co., St. Louis, MO, USA); and human insulin (Actrapid, CSL-Novo, North Rocks, Australia). Steroids were stored at 7208C as 1000-fold-concentrated stock solutions in absolute ethanol. Cycloheximide (Calbiochem-Behring Corp., La Jolla, CA, USA) was dissolved at 20 mg/ml in water and ®lter sterilized. Actinomycin D (Cosmegen, Merck Sharp and Dohme Research Pharmaceuticals, Rahway, NJ, USA) was dissolved at 0.5 mg/ml in sterile water and used immediately. Tissue culture reagents were purchased from standard sources.
Cell culture
The sources and maintenance of the human breast cancer and normal cell lines used in this study were as described previously (Buckley et al., 1993; Hamilton et al., 1997) , as were tissue culture experiments (Hamilton et al., 1997) . Brie¯y, progestin (ORG 2058, 10 nM) and/or cycloheximide (20 mg/ml) or actinomycin D (5 mg/ml) was added to the medium and control¯asks received the same volume of vehicle alone. To obtain RNA for dierential display, cells were grown in insulin-supplemented serum-free medium and treated for 3 h with ORG 2058 or ethanol vehicle. Subsequent progestin stimulation experiments were carried out in medium containing 5% charcoal-stripped fetal calf serum without insulin.
RNA isolation and Northern analysis
Cells harvested from duplicate 150 cm 2¯a sks were pooled, RNA extracted by a guanidinium-isothiocyanate-cesium chloride procedure and Northern analysis was performed as previously described with 20 mg of total RNA per lane (Alexander et al., 1989; Musgrove et al., 1991) . The membranes were hybridized overnight (508C) with probes labeled with [a- 32 P]dCTP (Amersham Australia Pty Ltd) using a Prime-a-Gene labeling kit (Promega Corp., Sydney, Australia). The membranes were washed at a highest stringency of 0.26SSC (30 mM NaCl, 3 mM sodium citrate [pH 7.0])/1% sodium dodecyl sulfate at 658C and exposed to Kodak X-OMAT or BIOMAX ®lm at 7708C. Human multiple tissue Northern blots or RNA Master blot (CLONTECH Laboratories Inc., Palo Alto, CA, USA) were hybridized under conditions recommended by the manufacturer. The mRNA abundance was quantitated by densitometric analysis of autoradiographs using Molecular Dynamics Densitometer and software (Molecular Dynamics, Sunnyvale, CA, USA). The accuracy of loading was estimated by re-hybridizing membranes with a [g-32 P]ATP end-labeled oligonucleotide complementary to 18S rRNA (Chan et al., 1984; Hall et al., 1990) .
Dierential display
Dierential display was carried out as described (Liang and Pardee, 1992) The PCR products were denatured and separated on a 4.5% denaturing polyacrylamide gel at 800 v for 16 h using the Genomyx Long Read Sequencing System reagents and apparatus. The gel was dried on the glass plate and exposed to X-ray ®lm for 16 ± 72 h. The DD-PCR product of interest was excised from the gel and ampli®ed by PCR under the conditions recommended by the kit manufacturer using an M13 forward primer (5'AGCGGATAACAATTTCACACAGGA) and a T7 promoter primer (5'TAATACGACTCACTATAGGG). The reampli®ed PCR products were puri®ed from 0.8% agarose gels using QIAEX reagents (Qiagen Pty Ltd, Clifton Hill, Australia).
Cloning and sequencing of cDNAs
Double stranded DNA templates were sequenced using the fmol DNA Cycle Sequencing System (Promega Corp.) with 33 P-labeled primers. The M13 primer was used for direct sequencing of DD-PCR products and the T7 and SP6 (5'GATTTAGGTGACACTATAG) promoter primers were used for sequencing PCR products cloned into the pGEM-T vector (Promega Corp.). Sequence database searches were performed at the NCBI using the Blast or Fasta network services. Peptide motif searches were carried out against the Prosite database.
Two primers (FC2: 5'GACGAAGGGCCCTGACTGC-GCGAGAAGAAGC and R2: 5'AAAGAATTCTGTCA-TGGAGTCTGAACGTCG) that¯ank the region containing the reported rat 100 kDa start codon (Muller et al., 1992) were used to amplify cDNA extracted from a rat hypothalamus library (CLONTECH). The resulting PCR product was cloned into pGEM-T (Promega Corp.) and four clones were sequenced.
Rapid ampli®cation of cDNA 5' ends (5' RACE)
Additional sequence was obtained with the aid of a 5'RACE kit (Life Technologies Inc., Gaithersburg, MD, USA), following the manufacturer's instructions. Brie¯y, a gene speci®c primer (GSP1: 5'CACGCTCCAATG-CAAGCTGG) was used to prime ®rst strand cDNA synthesis. Following removal of the RNA strand, cDNA was 5' poly dC tailed and ampli®ed by PCR. The target cDNA was ampli®ed using an anchor primer (UAP: 5'GGCCACGCGTCGACTAGTACGGGIIGGGII-GGGIIG, where I represents deoxyinosine) in combination with a second gene speci®c primer (GSP2: 5'CGA-TCTTCCCTGATTCGAGGTGGC). Various gel-puri®ed PCR products were further PCR ampli®ed, primed by UAP and a third gene speci®c nested primer (GSP3: 5'CTGTATTGACAATGCTCCACC).
cDNA library screening 10 6 plaques from a human heart cDNA library in the Lambda ZAPII vector primed with both oligo (dT) and random primers (Stratagene, La Jolla, CA, USA) were transferred to nylon membranes (Hybond N, Amersham Australia Pty Ltd) and screened with both the original DD-PCR fragment and the RACE product as 32 P-labeled probes. This led to isolation of clone H1 (2.55 kb). This clone and the RACE product were used to screen 10 6 recombinants from a human placenta 5'STRETCH PLUS cDNA library in lgt10 primed with both oligo (dT) and random primers (CLONTECH Laboratories, Inc.). Sequencing of cDNA clones in either pBluescript or lgt10 was carried out as described above using vector-or genespeci®c primers. Several rounds of isolation of positive clones and further screening of this library led to the isolation of the following overlapping clones covering the entire EDD open reading frame: P61 (1.95 kb), P43 (2.1 kb), P1 (1.5 kb), P19 (3 kb) and P47 (2.1 kb).
Fluorescence in situ hybridization
A probe corresponding to clone H1 was nick-translated with biotin-14-dATP and hybridized in situ at a ®nal concentration of 20 ng/ml to metaphases from two normal males. The¯uorescence in situ hybridization (FISH) method was modi®ed from that previously described (Callen et al., 1990) in that chromosomes were stained before analysis with both propidium iodide (as counterstain) and DAPI (for chromosome identi®cation). Images of metaphase preparations were captured by a CCD camera using the CytoVision Ultra image collection and enhancement system (Applied Imaging Int Ltd). FISH signals and the DAPI banding pattern were merged for ®gure preparation.
Construction of recombinant cDNA clones for in vitro translation and protein expression
The full length EDD sequence was cloned by ligating three PCR products which spanned the open reading frame into pBluescript. The existing SalI and EcoRI restriction sites used to ligate the fragments are indicated in Figure 3a . The carboxyl third of the cDNA was cloned into pBluescript such that a 890 amino acid truncated protein corresponding to the predicted rat 100 kDa protein (from aa 1910 to aa 2799) would be translated. An identical truncated cDNA fragment was cloned into the pFastBac1 expression vector (Life Technologies Inc.) for protein expression using the Bac-To-Bac baculovirus expression system in Spodoptera frugiperda (Sf9) cells and full length EDD cDNA was cloned into the pRcCMV expression vector (Invitrogen, Leek, The Netherlands) for transient transfection into HEK-293 cells. Mutagenesis of cysteine 2768 to alanine was performed for full length and truncated constructs in pBluescript using the Quick-Change site-directed mutagenesis kit (Stratagene). In vitro transcription and translation were performed using the TNT T7 Quick coupled rabbit reticulocyte lysate system (Promega Corp.) and [
35 S]-methionine (1000 Ci/mmole, ICN Biomedicals Australasia Pty Ltd, Seven Hills, Australia).
SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotting
Cells growing in mid-log phase were lysed in 1% Triton X-100 buer containing 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; pH 7.5), 150 mM NaCl, 10% glycerol, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM sodium pyrophosphate, 20 mM sodium¯uoride, 1 mM dithiothreitol (DTT), 10 mg/ml each of aprotonin and leupeptin, 1 mM phenylmethylsulfonyl¯uoride (PMSF) and 200 mM sodium orthovanadate. Lysates were cleared by centrifugation, quantitated according to a modi®ed Bradford method (Bio-Rad Laboratories, Hercules, CA, USA) and typically 40 mg of total protein in SDS-sample buer (50 mM TrisHCl, pH 6.8, 2% SDS, 10% glycerol, and 0.2% bromophenol blue) containing 5% b-mercaptoethanol were resolved on 6% SDS-polyacrylamide gels. Following electrophoresis proteins were transferred to nitrocellulose (TransBlot, Bio-Rad Laboratories) and subjected to immunodetection. An EDD-speci®c peptide (SSEKVQ-QENRKRHGSS) was synthesized, coupled via glutaraldehyde to diptheria toxoid and used to generate a rabbit anti-EDD antibody (designated AbPEP1).
Immunoprecipitation
Cleared cell lysates (typically 1 mg total protein) or in vitro translation reactions were incubated with either control rabbit serum or AbPEP1 in the presence or absence of a tenfold excess of competing peptide for 1 ± 2 h at 48C. Following incubation with Protein A Sepharose 4B (Zymed, San Francisco, CA, USA), immunoprecipitates were washed three times in 1% Triton X100 lysis buer described above, resolved by SDS ± PAGE and either transferred to nitrocellulose and immunoblotted with AbPEP1 or where applicable dried onto Whatman 3 MM paper and subjected to autoradiography.
Ubiquitin-binding assay
35 S-labeled in vitro translated truncated (*100 kDa) or full length protein was tested for its ability to bind ubiquitin by incubating 5 ml translation reaction with or without 5 mg puri®ed GST protein or GST-ubiquitin fusion protein for 10 min at 258C . Reactions were terminated by incubating the mixtures in either SDSsample buer containing 100 mM DTT at 958C for 5 min or in SDS-sample buer containing 4 M urea instead of DTT at 258C for 20 min. Samples were resolved by SDS ± PAGE through 6% or 7% gels followed by drying and autoradiography.
